Buspirone Hydrochloride Tablet
Product Images NDC 64980-654

Product Visual Gallery

This gallery contains 17 technical images submitted to the FDA as part of the official labeling for Buspirone Hydrochloride (NDC 64980-654). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Rising Pharma Holdings, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Image (66cf8d73 Ea13 47fe Be0f 45edd9101d2d 01)

Chemical structure diagram of Buspirone Hydrochloride showing molecular connectivity including cyclohexane rings, nitrogen atoms, and a hydrochloride group (HCl).*

FDA Label Image

Image (66cf8d73 Ea13 47fe Be0f 45edd9101d2d 02)

Buspirone Hydrochloride oral tablet blister pack containing three tablets with dosages labeled as 5 mg, 3 mg, and 2 mg respectively. The tablets are organized side by side in a single strip. Labeler information is not visible in the image.*

FDA Label Image

Image (66cf8d73 Ea13 47fe Be0f 45edd9101d2d 03)

Image of a white, oblong buspirone hydrochloride tablet scored with three grooves, dividing it into four sections. The tablet is intended for oral administration and is part of the Rising Pharma Holdings, Inc. product line.*

FDA Label Image

Image (66cf8d73 Ea13 47fe Be0f 45edd9101d2d 04)

Buspirone Hydrochloride tablet scored with imprint "23" visible in gray on a white oval tablet. The image shows a single oral tablet dosage form by Rising Pharma Holdings, Inc.*

FDA Label Image

Image (66cf8d73 Ea13 47fe Be0f 45edd9101d2d 05)

FDA Label Image

Image (66cf8d73 Ea13 47fe Be0f 45edd9101d2d 06)

Buspirone Hydrochloride 10 mg oral tablet imprint showing the code '2 S'. The image displays one white, round tablet with the imprint code visible. Manufactured by Rising Pharma Holdings, Inc.*

FDA Label Image

Image (66cf8d73 Ea13 47fe Be0f 45edd9101d2d 07)

Buspirone Hydrochloride oral tablet in a blister pack showing the numbers '2', '3', and '3' embossed on individual tablets. The image highlights the shape and imprint on the tablets, consistent with the product's available strengths. No other packaging or labeling information is visible.*

FDA Label Image

Image (66cf8d73 Ea13 47fe Be0f 45edd9101d2d 08)

Buspirone Hydrochloride oral tablets in a white, rectangular blister pack with three distinct tablet compartments. The labeler Rising Pharma Holdings, Inc. is associated with this product. Specific tablet strength or count is not visible on the pack.*

FDA Label Image

Image (66cf8d73 Ea13 47fe Be0f 45edd9101d2d 09)

Packaging label showing a blister pack segment containing two tablets labeled with the numbers 2 and 3. The image is part of a medication package, likely corresponding to Buspirone Hydrochloride tablets by Rising Pharma Holdings, Inc., available in various strengths including 5 mg, 7.5 mg, 10 mg, 15 mg, and 30 mg.*

FDA Label Image

Image (66cf8d73 Ea13 47fe Be0f 45edd9101d2d 10)

An illustration of a single tablet, showing the tablet's shape and an engraving of the number '2' on one side. The image highlights tablet imprint detail for identification purposes.*

FDA Label Image

Image (66cf8d73 Ea13 47fe Be0f 45edd9101d2d 11)

Partial image of a blister pack showing a section with the number '21' and adjacent partial number '2'. The pack is typically used for oral tablets like Buspirone Hydrochloride. No brand or strength information is visible in this segment.*

FDA Label Image

Image (66cf8d73 Ea13 47fe Be0f 45edd9101d2d 12)

An instructional illustration showing two hands holding a tablet, demonstrating how to split the tablet by applying pressure with fingers from both sides. No branding or additional text is visible in the image.*

FDA Label Image

Image (66cf8d73 Ea13 47fe Be0f 45edd9101d2d 13)

Label for Buspirone Hydrochloride Tablets, USP 5 mg oral tablets, containing 60 tablets per bottle. The label indicates prescription use only (Rx only) and advises pharmacists to dispense patient information leaflets. Manufactured by Graviti Pharmaceuticals Pvt. Ltd. for Rising Pharma Holdings, Inc. Storage instructions and dosage warnings are also included.*

FDA Label Image

Image (66cf8d73 Ea13 47fe Be0f 45edd9101d2d 14)

Label for Buspirone Hydrochloride Tablets, USP 7.5 mg, containing 100 tablets. The label shows dosage form as tablet with oral route and indicates prescription use only (Rx only). It includes storage instructions and manufacturer details for Rising Pharma Holdings, Inc., with a barcode and NDC number 64980-651-01.*

FDA Label Image

Image (66cf8d73 Ea13 47fe Be0f 45edd9101d2d 15)

Label for Buspirone Hydrochloride Tablets, USP 10 mg, oral tablets. The label indicates 60 tablets per bottle, with the product manufactured for Rising Pharma Holdings, Inc. It includes storage instructions, dispensing guidance, and a barcode. The label states the tablets contain 10 mg of Buspirone Hydrochloride and are Rx only.*

FDA Label Image

Image (66cf8d73 Ea13 47fe Be0f 45edd9101d2d 16)

Buspirone Hydrochloride Tablets, USP 15 mg oral tablets by Rising Pharma Holdings, Inc. The label indicates a quantity of 60 tablets. It includes dosage strength, storage instructions, manufacturer details (Graviti Pharmaceuticals Pvt. Ltd., India), and a barcode. The label emphasizes dispensing with patient information leaflets and states prescription only (Rx only).*

FDA Label Image

Image (66cf8d73 Ea13 47fe Be0f 45edd9101d2d 17)

Buspirone Hydrochloride 30 mg oral tablets label by Rising Pharma Holdings, Inc. The label states the product name, strength, and dosage form with a quantity of 60 tablets. It includes storage instructions, dispensing directions, manufacturer information, and a barcode. The label also highlights that it is an Rx only prescription drug.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.